Biological
Engerix-B clinical trials
Also written Engerix-B.
- studies test it
- 29
- open now
- 1
- in phase 3
- 6
- first study started
- 1992
Keep track of what changes. Save the Engerix-B studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Combined with it in one product
Studies by the year they started
29 studies that test it; most in 2004 (3)
| Year | Studies |
|---|---|
| 1992 | 1 |
| 1995 | 1 |
| 1998 | 1 |
| 1999 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 4
- Phase 3
- 6
- Phase 4
- 17
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 14
GlaxoSmithKline (14) · Chang Gung Memorial Hospital (2) · University of North Carolina, Chapel Hill (2) · Centre for Infectious Disease Research in Zambia (1) · Sheffield Teaching Hospitals NHS Foundation Trust (1) · Soroka University Medical Center (1) · Sanofi Pasteur, a Sanofi Company (1) · Laval University (1)
Often tested with
Tested in the same studies.
Hepatitis A Vaccines (2) · Fendrix (1) · Tenofovir (1) · Entecavir (1) · GSK257049 (1) · Twinrix (1) · Human papillomavirus vaccine, L1 type 16, 18 (1)
Studies
Open first, then newest update. How each study uses Engerix-B is read from its arms, and is right about nine times in ten.
Testing it · 29
- Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCDRecruitingNot applicableAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT05200338Written as Engerix-B
- Demonstration Project on Health Care Worker Protection Against Hepatitis B in Kalulushi DistrictCompletedPhase 4Centre for Infectious Disease Research in ZambiaNCT04072211Written as Engerix-B
- A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination CoursesCompletedPhase 2/3Sheffield Teaching Hospitals NHS Foundation TrustNCT02434848Written as Engerix B
- Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV InfectionStatus unknownPhase 4National Taiwan University HospitalNCT03854630Written as Engerix-B
- Hepatitis B Vaccine in Patients With Inflammatory Bowel DiseaseCompletedNot applicableSoroka University Medical CenterNCT01531075Written as ENGERIX-B (HBV Vaccine)
- Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-BCompletedPhase 4GlaxoSmithKlineNCT02901951Written as Engerix-B
- Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues TherapyCompletedPhase 4Chang Gung Memorial HospitalNCT02505009Written as Engerix-B
- Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 YrsCompletedPhase 3GlaxoSmithKlineNCT00343915Written as Engerix™-B (thiomersal-free) 20µg
- Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix AdultCompletedPhase 4GlaxoSmithKlineNCT01037114Written as Engerix-B
- Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B VaccineCompletedPhase 4GlaxoSmithKlineNCT00524576Written as Engerix™-B
- Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix AdultCompletedPhase 4GlaxoSmithKlineNCT01000324Written as Engerix-B
- Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated ChildrenCompletedPhase 4GlaxoSmithKlineNCT01138098Written as Engerix™-B
- Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African InfantsCompletedPhase 2GlaxoSmithKlineNCT01231503Written as Engerix-B
- HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAgStatus unknownPhase 3Mahidol UniversityNCT03405597Written as Commercial Hepatitis B vaccine
- A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXACompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT00693186Written as Engerix B® 10 µg / 0.5 mL
- Hepatitis B Vaccine in Chronic Hepatitis B Patients With Low Serum HBsAgCompletedPhase 1Chang Gung Memorial HospitalNCT01817725Written as HBV vaccine (Engerix B)
- Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive YouthCompletedPhase 4University of North Carolina, Chapel HillNCT00106964Written as Engerix-B 20 mcg
- Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 YearsCompletedPhase 3GlaxoSmithKlineNCT00383591Written as Engerix-B
- Immunologic Memory (Supp. of ATN 024)CompletedPhase 4University of North Carolina, Chapel HillNCT00142753Written as Engerix B
- Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B VaccineCompletedPhase 4GlaxoSmithKlineNCT00657657Written as Engerix™-B
See all 29 studies that test Engerix-B →
Given in every arm · 4 — Engerix-B is usual care beside what is tested
- The COMBAT HBV Feasibility TrialCompletedPhase 4University of North Carolina, Chapel HillNCT05705427Written as Hepatitis B monovalent vaccine
- Arresting Vertical Transmission of Hepatitis B VirusCompletedPhase 4University of North Carolina, Chapel HillNCT03567382Written as Monovalent HBV vaccine
- Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy AdolescentsCompletedPhase 4GlaxoSmithKlineNCT00534638Written as Engerix-B
- LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ MothersCompletedPhase 4GlaxoSmithKlineNCT00240526Written as Engerix™ -B
As the comparator · 49 — what is tested is compared with Engerix-B
- A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus InfectionNot yet recruitingPhase 1/2Vaxine Pty LtdNCT03038802Written as Commercial Hepatitis B vaccine
- Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)Not yet recruitingPhase 3PT Bio FarmaNCT05482295Written as Registered Hepatitis B vaccine recombinant (Engerix-B)
- A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 YearsCompletedPhase 1GlaxoSmithKlineNCT05561673Written as GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide
- B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-BCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT04193189Written as ENGERIX-B
- Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in MaliCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT02942277Written as Engerix-B
- A Bridging Study: Comparing Two Lots of Sci-B-Vac™ and Engerix-B in Healthy AdultsCompletedPhase 3VBI Vaccines Inc.NCT04531098Written as Engerix-B
- Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B®CompletedPhase 3VBI Vaccines Inc.NCT04209400Written as Engerix-B®
- Non Inferiority Trial of Locally Manufactured 'Hepa-B' Vaccine in Bangladesh.CompletedPhase 2/3International Centre for Diarrhoeal Disease Research, BangladeshNCT03627507Written as Engerix B
- Comparing Safety and Immunogenicity of HEPLISAV-B® to Engerix-B® in Chronic Kidney Disease (CKD) PatientsCompletedPhase 3Dynavax Technologies CorporationNCT00985426Written as Engerix-B
- Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian InfantsCompletedPhase 2GlaxoSmithKlineNCT00289185Written as Engerix-B®
- Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy InfantsCompletedPhase 3GlaxoSmithKlineNCT02096263Written as Engerix-B
- Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B VaccCompletedPhase 4GlaxoSmithKlineNCT00289731Written as Engerix™-B
- COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate VaccineCompletedPhase 3GlaxoSmithKlineNCT00466947Written as Engerix-B
- Safety and Immunogenicity of HEPLISAV™ a Hepatitis B Virus Vaccine in Adults on HemodialysisCompletedPhase 3Dynavax Technologies CorporationNCT01195246Written as Engerix-B
- Safety and Efficacy of HEPLISAV™ Hepatitis B Virus Vaccine Compared With Engerix-B® VaccineCompletedPhase 3Dynavax Technologies CorporationNCT00435812Written as Engerix-B
- Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® VaccineCompletedPhase 3Dynavax Technologies CorporationNCT02117934Written as Engerix-B
- Safety and Immunogenicity Study of the Hepatitis B Virus (HBV) Vaccine, HEPLISAV Compared to Engerix-B VaccineCompletedPhase 3Dynavax Technologies CorporationNCT01005407Written as Engerix-B
- Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant SystemCompletedPhase 2GlaxoSmithKlineNCT01777295Written as EngerixTM-B
- Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B VaccineCompletedPhase 2GlaxoSmithKlineNCT00805389Written as Engerix-B™
- Examine Safety and Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-endemic RegionCompletedPhase 2GlaxoSmithKlineNCT00197028Written as Engerix-B®
Showing 20 of 49.
Codes
What other systems call Engerix-B · ClinicalTrials.gg INT003644
- RxNorm 1427171One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 1427171 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.